Vascular changes in hemodialysis patients in response to recombinant human erythropoietin
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 36 (5) , 878-882
- https://doi.org/10.1038/ki.1989.274
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Recombinant Human Erythropoietin: Implications for NephrologyAmerican Journal of Kidney Diseases, 1988
- Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.BMJ, 1987
- Uremic cardiomyopathy: An inadequate left ventricular hypertrophyKidney International, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- ERYTHROPOIETIN TREATMENT IN ANAEMIC PATIENTS ON HAEMODIALYSISThe Lancet, 1986
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977
- Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergyThe American Journal of Cardiology, 1976
- Comparison of Ultrasound and Cineangiographic Measurements of the Mean Rate of Circumferential Fiber Shortening in ManCirculation, 1972